|Title:||An Audit on the Baseline Extra-Pulmonary Screening Investigations of Biopsy-Confirmed Sarcoidosis Patients in Mater Misericoardiae University Hospital|
|Author(s):||A Asis D Halim N Boyle A Kirk T McEnery|
|Institution:||Mater Misericordiae University Hospital|
|Poster:||Click to view poster|
|Abstract:||The clinical presentation of sarcoidosis can vary from an asymptomatic state to multi-system involvement. Early detection and timely treatment for asymptomatic extra-pulmonary disease can reduce unnecessary consequences. For this reason, the American Thoracic Society (ATS) have guidelines for the screening of extra-pulmonary involvement at the time of diagnosis. |
This audit aimed to assess local practice in Mater Hospital of screening for extra-pulmonary involvement in the biopsy-proven pulmonary sarcoidosis patients against the ATS guideline.
A total of 69 patients were diagnosed over the course of the audit timeline from January 2015 to January 2020. 38 patients were excluded as they were referred externally for biopsy but followed up outside Mater Hospital. Table 1 summarises the findings from the audit.
This audit suggested that our adherence to the ATS screening guideline is variable with none of investigations achieved 100% standard. The implementation of ocular and cardiac investigations is poor with either under or over-ordered. ACE levels was still being ordered even though it is not in the guideline.
In conclusion, an increased awareness of the recommended screening tests is warranted in order to detect occult extra-pulmonary involvement and to ensure hospital resources are utilised efficiently.